From jamie.goodwin@hullcc.gov.uk | Friday 12 June 2020
The centre will improve accuracy and detection rates for cancer, heart disease and dementia in Hull, East Yorkshire and North Lincolnshire.
The first pictures have been released of a state-of-the-art £8.5 million molecular imaging research centre to be built at Castle Hill Hospital near Hull.
The centre will improve accuracy and detection rates for cancer, heart disease and dementia in Hull, East Yorkshire and North Lincolnshire.
And a charity behind the scheme has set a target for completion by the end of this year - and operation early in 2021 - after construction resumed at the site.
The Daisy Appeal’s objective is to establish an internationally renowned scanning centre using positron emission tomography, a fast-evolving medical imaging technique with huge future potential in the diagnosis and detailing of a number of disease processes.
Professor Steve Archibald, of the Positron Emission Tomography Research Centre at the University of Hull’s Faculty of Health Sciences, said: “It’s a really impressive building that looks like it’s come down from outer space and landed on the hospital site. Patients don’t go in there but they benefit from what comes out.”
The charity funded a research and development facility – the Daisy Building – which opened at Castle Hill in 2008 at a cost of £8.5 million and followed that by opening the £4.7 million Jack Brignall PET-CT Scanning Centre in 2014.
Prof Archibald said: “What we want to do is see what’s going on inside you and see that to a great level of detail. The excitement is about what’s developing and finding signs of things like Alzheimer’s before they develop. We want to get clinical trials going on and new therapies developed in Hull."
To find out more about the Daisy Appeal and to make a donation, visit www.daisyappeal.org
